TIMP1 and neoplasm: TIMP1 (Tissue Inhibitor of Metalloproteinases 1), which is overexpressed in OC, has been shown to affect the tumor microenvironment (TME) by altering the behavior of both tumor and endothelial cells, leading to drug resistance, particularly in advanced OC patients37.